For Reporting Doctors

For reporting doctors

Cancer registration is intended to improve knowledge about the disease and the quality of treatment. However, analyses and statistics are only meaningful if the data basis is valid. The completeness and quality of our data depends crucially on your cooperation. On the pages below, you will learn how to support the cancer registry with your reports.

Legal framework

The legal framework for the reporting procedure is defined in the Cancer Registry Act (BremKRG). You can find out more about for whom a reporting obligation exists,
when you have to initiate a report and which deadlines you have to observe here.

Data set

The data set collected by the cancer registry corresponds to the uniform basic
oncology data set of the Working Group of German Tumor Centers and the Society of Epidemiological Cancer Registries in Germany. Here you will find more information.

Reporting process

Reports on new cancer cases, therapies and courses of disease are to be transmitted in structured electronic form to the trust center of the Bremen Cancer Registry. You
can learn more about the most important aspects of this process here.

Patient information

Every affected patient has the right to be informed about the report to the cancer registry. The reporting institution is under the obligation and responsibility to provide
the information. Learn more about it here.

Feedback of treatment data

To promote direct patient-related cooperation, you have the opportunity of requesting the transmission of medical data stored in the cancer registry for the patients on
whom you are reporting. Click here to learn more.

Reporting compensation

On this page, you will find information on the requirements for and amounts of compensation as well as on our procedures. The Bremen Cancer Registry will pay
you a compensation for expenses for each complete and valid report.

Frequently asked questions

Find answers to frequently asked questions (FAQ) on different topics concerning the Bremen Cancer Registry here.